Interleukin-6 polymorphisms, Helicobacter pylori infection in adult Brazilian patients with chronic gastritis and gastric adenocarcinoma

被引:53
作者
Lobo Gatti, Luciano
Burbano, Rommel Rodriguez
Zambaldi-Tunes, Mauricio
de-Labio, Roger Willian
de Assumpcao, Paulo Pimentel
Cardoso-Smith, Marilia de Arruda
Marques-Payao, Spencer Luiz
机构
[1] Fac Med Marilia, Dipciplina Genet & Biol Mol, BR-17519050 Marilia, SP, Brazil
[2] Univ Fed Sao Paulo, EPM, BR-04023062 Sao Paulo, Brazil
[3] Fed Univ Para, Ctr Ciencias Biol, Dept Biol, BR-66059 Belem, Para, Brazil
[4] Fed Univ Para, Hosp Univ Joao Barros Barreto, Dept Patol, BR-66059 Belem, Para, Brazil
基金
巴西圣保罗研究基金会;
关键词
interleukin-6; polymorphism; gastric cancer; helicobacter pylori;
D O I
10.1016/j.arcmed.2006.12.011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Background. The discovery of Helicobacter pylori offered the etiologic agent of the initiating event of the inflammatory cascade. It has been confirmed that the development of gastric cancer spans over several decades sequentially starting with the acquisition of H. pylori infection and the development of chronic gastritis. The IL-6 gene (Il-6), inflammatory cytokine and the single-nucleotide polymorphisms (SNPs) at the 5' flanking region of the Il-6 gene promoter (G or C at - 174 base and at - 572 or - 597 C or A) have been identified with increased Il-6 levels. Methods. Biopsies were collected from 168 patients. SNPs in Il-6 - 174 were analyzed by PCR-RFLP. Results. Promoter SNP of Il-6 at - 174 base were within Hardy-Weinberg equilibrium. We did not find any association between the frequencies of - 174 polymorphism with specific histological type of gastric adenocarcinoma, but the G (guanine) allele at - 174 was significantly higher in gastric adenocarcinoma than in patients with chronic gastritis. Conclusions. We observed an association between GG allele on - 174 base with gastric cancer. (c) 2007 IMSS. Published by Elsevier Inc.
引用
收藏
页码:551 / 555
页数:5
相关论文
共 34 条
[1]
Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: Role of IL-6 as a prognostic factor [J].
Ashizawa T. ;
Okada R. ;
Suzuki Y. ;
Takagi M. ;
Yamazaki T. ;
Sumi T. ;
Aoki T. ;
Ohnuma S. ;
Aoki T. .
Gastric Cancer, 2005, 8 (2) :124-131
[2]
Bodger K, 1998, BRIT MED BULL, V54, P139
[3]
Age at acquisition of Helicobacter pylori infection:: Comparison of two areas with contrasting risk of gastric cancer [J].
Camargo, MC ;
Yepez, MC ;
Ceron, C ;
Guerrero, N ;
Bravo, LE ;
Correa, P ;
Fontham, ETH .
HELICOBACTER, 2004, 9 (03) :262-270
[4]
NEW ELEMENTS FOR AN UPDATED CLASSIFICATION OF THE CARCINOMAS OF THE STOMACH [J].
CARNEIRO, F ;
SEIXAS, M ;
SOBRINHOSIMOES, M .
PATHOLOGY RESEARCH AND PRACTICE, 1995, 191 (06) :571-584
[5]
CORREA P, 1988, CANCER RES, V48, P3554
[6]
MUCOSAL TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 IN PATIENTS WITH HELICOBACTER-PYLORI ASSOCIATED GASTRITIS [J].
CRABTREE, JE ;
SHALLCROSS, TM ;
HEATLEY, RV ;
WYATT, JI .
GUT, 1991, 32 (12) :1473-1477
[7]
A primer on cytokines: Sources, receptors, effects, and inducers [J].
Curfs, JHAJ ;
Meis, JFGM ;
HoogkampKorstanje, JAA .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) :742-+
[8]
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms [J].
El-Omar, EM ;
Rabkin, CS ;
Gammon, MD ;
Vaughan, TL ;
Risch, HA ;
Schoenberg, JB ;
Stanford, JL ;
Mayne, ST ;
Goedert, J ;
Blot, WJ ;
Fraumeni, JF ;
Chow, WH .
GASTROENTEROLOGY, 2003, 124 (05) :1193-1201
[9]
Interleukin-1 polymorphisms associated with increased risk of gastric cancer [J].
El-Omar, EM ;
Carrington, M ;
Chow, WH ;
McColl, KEL ;
Bream, JH ;
Young, HA ;
Herrera, J ;
Lissowska, J ;
Yuan, CC ;
Rothman, N ;
Lanyon, G ;
Martin, M ;
Fraumeni, JF ;
Rabkin, CS .
NATURE, 2000, 404 (6776) :398-402
[10]
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis [J].
Fishman, D ;
Faulds, G ;
Jeffery, R ;
Mohamed-Ali, V ;
Yudkin, JS ;
Humphries, S ;
Woo, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1369-1376